| TU-100 for Accelerating GI Recovery After Major Abdominopelvic Surgery (RC & CAWR) (NCT07765589) | Tsumura USA | 2026-12-01 |
| Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma (NCT07634289) | Olivia Newton-John Cancer Research Institute | 2026-12-01 |
| A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Prevention: Rimegepant Versus Flunarizine Non-inferiority Study (NCT07751497) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-12-01 |
| BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma and Multiple Myeloma (NCT07771361) | Luminary Therapeutics | 2026-12-01 |
| Efficacy and Safety of Spironolactone in Pediatric Hemodialysis Patients With Anemia. (NCT07715318) | Ain Shams University | 2026-12-01 |
| Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilities (NCT07564934) | University of Alabama at Birmingham | 2026-12-01 |
| PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP) (NCT07477418) | University of Vermont | 2026-12-01 |
| Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS) (NCT02478450) | Q Therapeutics, Inc. | 2026-12-01 |
| Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity (NCT06180616) | Royal North Shore Hospital | 2026-12-01 |
| Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade Gliomas (NCT07649070) | M.D. Anderson Cancer Center | 2026-11-30 |
| Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer (NCT07714447) | Sun Yat-sen University | 2026-11-30 |
| Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML (NCT07604233) | M.D. Anderson Cancer Center | 2026-11-30 |
| Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer (NCT07579221) | M.D. Anderson Cancer Center | 2026-11-30 |
| Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma (NCT07655570) | M.D. Anderson Cancer Center | 2026-11-30 |
| Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy (NCT07578025) | City of Hope Medical Center | 2026-11-28 |
| A Phase 1b/2 Study of Ropeginterferon Alfa-2b Added to Azacitidine in Newly Diagnosed MDS/AML (≥ 10% Blasts) With TP53 Mutations (NCT07646821) | M.D. Anderson Cancer Center | 2026-11-27 |
| Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma (NCT07281417) | National Cancer Institute (NCI) | 2026-11-24 |
| Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism (NCT07471230) | Biocells Medical | 2026-11-23 |
| A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01) (NCT07700758) | Merck Sharp & Dohme LLC | 2026-11-23 |
| A Study Evaluating the Safety, Tolerability, and Activity of ICM-203 in Subjects With Knee Osteoarthritis. (NCT05454566) | ICM Co. Ltd. | 2026-11-15 |
| Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas (NCT05253131) | University of Alabama at Birmingham | 2026-11-15 |
| Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans (NCT05145309) | University of Texas Southwestern Medical Center | 2026-11-15 |
| Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita (NCT07258173) | Jennifer Keiser | 2026-11-15 |
| Trial of Tirzepatide for the Treatment of Cannabis Use Disorder (NCT07468552) | National Institute on Drug Abuse (NIDA) | 2026-11-15 |
| Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer (NCT04181463) | M.D. Anderson Cancer Center | 2026-11-05 |
| Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial (NCT07610525) | M.D. Anderson Cancer Center | 2026-11-05 |
| Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negative Breast Cancer) (NCT07255612) | Sun Yat-sen University | 2026-11-04 |
| NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy (NCT07227909) | M.D. Anderson Cancer Center | 2026-11-04 |
| Alzheimer's Tau Platform: Regimen A - AADvac1 (NCT07167966) | Paul S. Aisen | 2026-11-03 |
| Targeting Interferon Gamma With Emapalumab to Lung Transplant Recipients With Interferon Gamma-high Acute Lung Allograft Dysfunction (NCT07538336) | University of California, San Francisco | 2026-11-02 |
| Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma (NCT07349693) | Everfront Biotech Co., Ltd. | 2026-11-01 |
| Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva (NCT07672782) | GOG Foundation | 2026-11-01 |
| Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers (NCT07126561) | University of Chicago | 2026-11-01 |
| Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung Cancer (NCT07759492) | Intergroupe Francophone de Cancerologie Thoracique | 2026-11-01 |
| Natural History of MTBI-related Convergence Insufficiency & Effectiveness of Vision Therapy for MTBI-related CI (NCT06848673) | Salus University | 2026-11-01 |
| Feasibility and Acceptability of Amani (NCT07648043) | Massachusetts General Hospital | 2026-11-01 |
| Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG) (NCT07206849) | Nationwide Children's Hospital | 2026-11-01 |
| [18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma (NCT07673341) | University of Washington | 2026-11-01 |
| Combined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal Cancer (NCT06557278) | Mirror Biologics, Inc. | 2026-11-01 |
| Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome (NCT04381897) | Johns Hopkins University | 2026-11-01 |
| Psilocybin Therapy for Methamphetamine Use Disorder and HIV (NCT07756736) | Nicky Mehtani, MD, MPH | 2026-11-01 |
| Autologous Tumor Infiltrating Lymphocyte (TIL) GT201 Infusion. (NCT07766317) | Gritbio Medicine, Inc. | 2026-11-01 |
| Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial (NCT07466498) | University of Washington | 2026-11-01 |
| Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II (NCT07513623) | University of California, San Francisco | 2026-11-01 |
| First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant (NCT07032038) | Rinri Therapeutics | 2026-11-01 |
| Gene-edited T Regulatory Cells (CRG-150) for the Treatment of Relapsed/Refractory Malignancies (NCT07730125) | CoRegen, Inc. | 2026-11-01 |
| Phase 2a Study to Evaluate the Efficacy and Safety of SCAI-005 Ophthalmic Solution in Subjects With Neovascular Age-related Macular Degeneration (NCT07607561) | SCAI Therapeutics | 2026-11-01 |
| Off-Label Treatment With Immune Checkpoint Inhibitor Blockade (NCT07754292) | Medical College of Wisconsin | 2026-11-01 |
| Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer (NCT07720167) | Medical University of South Carolina | 2026-11-01 |
| Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates (NCT07292298) | University of Colorado, Denver | 2026-11-01 |
| Reducing Opioid Use and Misuse After Wisdom Molar Extractions (NCT04414917) | Rutgers, The State University of New Jersey | 2026-11-01 |
| Bomedemstat (IMG-7289) in Combination With Momelotinib in Patients With Myelofibrosis (NCT07424950) | United Lincolnshire Hospitals NHS Trust | 2026-11-01 |
| Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis (NCT07750574) | Chengdu Zenitar Biomedical Technology Co., Ltd | 2026-11-01 |
| Role of Omega-DEK in Childhood Apraxia of Speech (NCT07216001) | Claudia R. Morris | 2026-11-01 |
| Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous Nephropathy (NCT07096986) | Centre Hospitalier Universitaire de Nice | 2026-11-01 |
| EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases (NCT05688241) | University Hospital, Basel, Switzerland | 2026-11-01 |
| A Study to Assess How Well the Study Medicine IPN60340 Works in Combination With Azacitidine and Venetoclax, Compared to Placebo in Combination With Azacitidine and Venetoclax, in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Cannot Receive Intensive Chemotherapy (NCT07623187) | Ipsen | 2026-11-01 |
| Inulin Supplementation for Reducing Inflammation and Knee Pain in Older Adults With Osteoarthritis (NCT07189585) | Yale University | 2026-11-01 |
| Pilot Testing of Vagus Nerve Stimulation for Early Spinal Cord Injury Recovery (NCT07562113) | University of Alabama at Birmingham | 2026-11-01 |
| OEA for Young Adults With Alcohol Use Disorder (NCT07503782) | Medical University of South Carolina | 2026-11-01 |
| Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets (NCT07234877) | European Organisation for Research and Treatment of Cancer - EORTC | 2026-11-01 |
| Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP) (NCT07521670) | National Cancer Centre, Singapore | 2026-11-01 |
| A Multicenter Phase II Trial to Evaluate Rechallenge With Platinum-based Chemotherapy (Carboplatin, Etoposide) for Progression During Tarlatamab Therapy in Relapsed Extensive Disease Small-cell Lung Cancer (SCLC) (NCT07699237) | University of Cologne | 2026-11-01 |
| Precision T1D Platform - New Therapies for Cardio-Renal Complications (NCT07594145) | Oregon Health and Science University | 2026-11-01 |
| 4AP for Carpal Tunnel Syndrome (CTS) (NCT06294821) | John Elfar | 2026-11-01 |
| Study of the Safety and Efficacy of Pancreatic Endocrine Cells in Adult Patients With Type 1 Diabetes (NCT07581197) | Seraxis | 2026-11-01 |
| Different Treatment Frequencies for Hepatic Fibrosis Due to Schistosomiasis (NCT07754617) | Rhode Island Hospital | 2026-11-01 |
| Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors (NCT06027983) | National University Hospital, Singapore | 2026-11-01 |
| Prescriptive Infusion Algorithm (PIA) (NCT07215403) | AskBio Inc | 2026-11-01 |
| A Novel Proline-rich Peptide Hydrogel for Periodontal Regeneration in Adult Periodontitis Patients (NCT07581613) | Siddharth Shanbhag | 2026-11-01 |
| A Phase 2a Study to Evaluate the Dose-response, Safety, Tolerability, Efficacy, and Population Pharmacokinetics of Intravenous NTS-521 Infusions in the Early Recovery Treatment From Acute Ischemic Stroke (NCT07742098) | NeuroTrauma Sciences, LLC | 2026-10-31 |
| Axelopran and Nivolumab in PD-1-Refractory Metastatic Melanoma (NCT07631325) | John Kirkwood | 2026-10-31 |
| Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases (NCT07258147) | Sichuan University | 2026-10-31 |
| Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma (NCT07689175) | University of Texas Southwestern Medical Center | 2026-10-31 |
| Fluorometholone Study (NCT07308938) | Vishal Jhanji | 2026-10-31 |
| Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer (NCT07101666) | Washington University School of Medicine | 2026-10-31 |
| Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma (NCT07731789) | University of Washington | 2026-10-31 |
| Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe Acne (NCT07756957) | Sanofi Pasteur, a Sanofi Company | 2026-10-30 |
| NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease (NCT07683325) | Agomab Spain S.L.U. | 2026-10-30 |
| Study of the Efficacy and Safety of a Bispecific Antibody, Teclistamab in Severe Rapidly Progressive Interstitial Lung Disease Associated With Anti-MDA5 (NCT07631208) | Assistance Publique - Hôpitaux de Paris | 2026-10-30 |
| Hyaluronic Acid vs I-PRF With Microneedling in Enhancing Peri-implant Soft Tissue (NCT07750756) | Ain Shams University | 2026-10-30 |
| Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar Depression (NCT07644767) | Neurocentrx Pharma Pty Ltd | 2026-10-30 |
| Microbiota trAnSplant ThERaPy In hEpatiC Encephalopathy (MASTERPIECE) (NCT07528690) | VA Office of Research and Development | 2026-10-30 |
| A 52-Week Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants With VEXAS Followed by Open-Label Extension (OLE) Period (NCT07748624) | Novartis Pharmaceuticals | 2026-10-30 |
| A Seamless, Adaptive Multiple-Ascending-Dose and Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations (NCT07680166) | Xentria, Inc. | 2026-10-30 |
| Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse (NCT07437963) | National Cancer Institute (NCI) | 2026-10-28 |
| A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects (NCT06964230) | T3D Therapeutics, Inc. | 2026-10-26 |
| A Study of LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have Symptomatic Raynaud's Phenomenon Attacks (NCT07748000) | Liquidia Technologies, Inc. | 2026-10-26 |
| ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia (NCT07420959) | Mayo Clinic | 2026-10-25 |
| hiPSC-CMs-loaded Chitosan Patch to Treat Severe Chronic Ischemic Heart Disease (NCT07471698) | HELP Therapeutics Co., Ltd. | 2026-10-20 |
| NAC-REPAIR for Post-surgical Pain (NCT07227649) | University of Arizona | 2026-10-15 |
| Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment (NCT07636564) | SWOG Cancer Research Network | 2026-10-14 |
| DOSE-UP: Dose Optimization for Smoking and E-Cigarette Use Pharmacotherapy (NCT07754578) | Medical University of South Carolina | 2026-10-10 |
| FLUDARABINE-TREOSULFAN REDUCED INTENSITY CONDITIONING REGIMEN PRIOR HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH POST TRANSPLANTATION CYCLOPHOSPHAMIDE FOR OLDER AND/OR FRAIL PATIENTS WITH AML (NCT07598110) | Institut Paoli-Calmettes | 2026-10-10 |
| Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms (NCT07549451) | M.D. Anderson Cancer Center | 2026-10-08 |
| Venetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (NCT07734038) | Kerry Rogers | 2026-10-07 |
| A Phase II Study of Zongertinib Plus Fulvestrant in Participants With HR-positive/HER2-negative Advanced Breast Cancer Harboring HER2 Mutations. (NCT07619066) | MedSIR | 2026-10-04 |
| Testing Mosunetuzumab Alone, With Zanubrutinib, or With Polatuzumab Vedotin for Treating Marginal Zone Lymphoma That Came Back or Didn't Get Better With Treatment (NCT07638722) | SWOG Cancer Research Network | 2026-10-03 |
| A Study of SL-325 in Crohn's Disease Patients (NCT07753850) | Shattuck Labs, Inc. | 2026-10-01 |
| Phase 2 Study of 500 mg BID NTZ on Top of Standard of Care in Patients With Acute Decompensation of Liver Cirrhosis at High Risk of Progression to Acute-on-Chronic Liver Failure or Established Acute-on-Chronic Liver Failure (NCT07694297) | Genfit | 2026-10-01 |